SCHEMBL20146595

SCHEMBL20146595

Cc1ccccc1N1C=CN(c2c(C(C)C)cccc2C(C)C)C1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
ESR1 P03372 1/20 0.38
FAAH O00519 2/20 0.36
MGLL Q99685 1/20 0.36
DPP4 P27487 2/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
C5AR1 P21730 3/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
ATP4A P20648 1/20 0.33
ATP4B P51164 1/20 0.33
MAPT P10636 1/20 0.33
ANPEP P15144 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19449636 1.00 TSHR (0.40) TSHRALDH1A1ALOX15ESR1FAAH
SCHEMBL17169612 1.00 TSHR (0.40) TSHRALDH1A1ALOX15ESR1FAAH
SCHEMBL23015446 0.95 ALDH1A1 (0.42) TSHRALDH1A1ALOX15ESR1FAAH
SCHEMBL17169610 0.85 MAPT (0.37) TSHRALDH1A1ESR1MGLLMAPT
SCHEMBL21074256 0.85 MAPT (0.37) TSHRALDH1A1ESR1MGLLMAPT
SCHEMBL13675478 0.85 GABRA1 (0.43) TSHRALDH1A1ALOX15FAAHMGLL
SCHEMBL17169526 0.84 HSD17B10 (0.34) TSHRALDH1A1ALOX15DPP4ANPEP
SCHEMBL19725777 0.83 ALDH1A1 (0.42) TSHRALDH1A1ESR1MGLLMAPT
SCHEMBL17169617 0.82 LMNA (0.33) TSHRALDH1A1ALOX15DPP4NR1H3
SCHEMBL17169581 0.81 ALDH1A1 (0.33) TSHRALDH1A1ALOX15C5AR1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11672176-B2 Host materials for electroluminescent devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-06 US disclosed
US-11254697-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-02-22 US disclosed
EP-3915996-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2021-12-01 EP disclosed
EP-3789379-A1 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS Universal Display Corporation (US) 2021-03-10 EP disclosed
US-20210024558-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-01-28 US disclosed
EP-3321258-B1 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS UNIVERSAL DISPLAY CORP (US) 2020-12-23 EP disclosed
EP-3323822-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2019-08-28 EP disclosed
EP-3321258-A1 4-PHENYLBENZO[G]QUINAZOLINE OR 4-(3,5-DIMETHYLPHENYLBENZO[G]QUINAZOLINE IRIDIUM COMPLEXES FOR USE AS NEAR-INFRARED OR INFRARED EMITTING MATERIALS IN OLEDS Universal Display Corporation (US) 2018-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254697-B2 Organic electroluminescent materials and devices LEF1, L1CAM, AP1M1 TSHR 1500/4885ALDH1A1 882/4885ALOX15 2558/4885
US-20210024558-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LEF1, L1CAM, AP1M1 TSHR 1500/4885ALDH1A1 882/4885ALOX15 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.